This suggests that a methyltransferase inhibitor/anti-PD-1+anti-CTLA-4 (cytotoxic T-lymphocyte-associated antigen 4) intervention can be used to inhibit tumor growth (70). The gene discussed is CTLA4; the disease is neoplasm.